Preclinical profiling of virosomally formulated B-cell epitope mimetics derived from the novel key malaria vaccine candidates CyRPA and RH5

Clinical testing of two components for a synthetic peptide-based virosomal malaria vaccine has yielded promising results, encouraging the search for additional components for inclusion in a final multivalent vaccine formulation. This CTI project should support design, optimisation and final…

01.09.2015 - 31.08.2017
Research project
Commission for Technology and Innovation (CTI)
MuLeVaClin - Clinical Studies on a Multivalent Vaccine for Human Visceral Leishmaniasis

Leishmaniasis was declared at the 60th WHO Assembly (2007) one of the world’s most neglected diseases. Leishmaniasis affects largely the poorest of the poor, mainly in developing countries as India, Bangladesh, Sudan, Ethiopia and Latin America. Existing treatments have severe drawbacks: side…

01.11.2013 - 30.09.2018
Clinical Trial
European Commission (EU) / 7th Framework programme